CTRI/2024/01/061760
Recruiting
Phase 2
A Comparative study on efficacy and safety of topical ozenoxacin 1 WW cream versus topical nadifloxacin 1 WW cream in mild to moderate facial acne vulgaris A randomized control trial - NI
ENDLURU SASIKALA0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ENDLURU SASIKALA
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Acne grades 1,2,3
- •At least 10 lesions
- •Agreed to sign consent
Exclusion Criteria
- •Usage of topical treatment I’m last 2 weeks, systemic antibiotics in last 4 weeks, chemical peeling in last 3 months, systemic isotretinoin in last 6 months
- •Hypersensitive to quinolones
- •Photosensitive condition/drugs
- •Pregnant/Lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A Comparative Study on efficacy and safety of topical 2% clotrimazole cream daily twice application with oral fluconazole and topical 1% Piroctone olamine daily night application with oral fluconazole teice per week for total of 4 weeks in the treatment of extensive dermatophytosisHealth Condition 1: B354- Tinea corporisCTRI/2022/10/046904Department of DV
Recruiting
Phase 4
Study of the effects of two eyedrops, Nepafenac and Flurbiprofen in reducing pain and inflammation in patients who are undergoing cataract surgery.CTRI/2017/01/007737Dr Saiyadali Allisabanavar80
Not yet recruiting
Phase 3
Comparison of effectiveness and safety of Topical clindamycin vs minocycline vs ozenoxacin in patients of Acne vulgarisHealth Condition 1: L700- Acne vulgarisCTRI/2024/03/064118OT APPLICABLE
Not yet recruiting
Phase 3
A Study to evaluate the effect of local application of Tulsi plant derived ointment comparing it with numbing gel Lidocaine in the management of mouth ulcers.CTRI/2024/07/069828Anu M
Not yet recruiting
Not Applicable
Pain levels during venepuncture: EMLA Vs 2% lignocaine gel;A randomised control trialCTRI/2019/04/018585Jisha johnson